Meda Pharmaceuticals Inc. drugs

4 results

  • depen

    (Penicillamine)
    Meda Pharmaceuticals Inc.
    DEPEN is indicated for treating Wilson’s disease, cystinuria, and severe rheumatoid arthritis in patients who have not responded to conventional therapy. It helps minimize copper intake and promotes copper excretion in Wilson’s disease, reduces cystine excretion to prevent stone formation in cystinuria, and assists in managing severe rheumatoid arthritis.
    Medication Details
    Drug Interactions

  • dymista

    (Azelastine Hydrochloride and Fluticasone Propionate)
    Meda Pharmaceuticals Inc.
    DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 6 years and older.
    Medication Details
    Drug Interactions

  • felbatol

    (felbamate)
    Meda Pharmaceuticals Inc.
    Felbatol® is indicated for patients with severe epilepsy who do not respond to other treatments. It may be used as monotherapy or adjunctive therapy for partial seizures in adults, and as adjunctive therapy for partial and generalized seizures in children with Lennox-Gastaut syndrome, with associated risks acknowledged.
    Medication Details
    Drug Interactions

  • soma

    (Carisoprodol)
    Meda Pharmaceuticals Inc.
    SOMA is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It should be used for short durations (up to three weeks) due to lack of evidence for longer-term effectiveness and the typically short duration of these conditions.
    Medication Details
    Drug Interactions